78
40
Growth Score 78 in past quarter
-7 pts
Heat Score 40 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4674872
PledPharma is a Swedish pharmaceutical company developing new therapies for life-threatening diseases.
Yilmaz Mahshid: CFOPast Role: Medivir, CEO
About the Company
PledPharma AB, a pharmaceutical company, develops various pharmaceutical products to treat life threatening diseases. It primarily develops PledOx that is in Phase IIb clinical trials to reduce severe side effects of chemotherapy in patients with colorectal cancer. The company’s project pipeline includes Aladote (PP-100), which is in the Phase II
clinical trials for the treatment of acute liver failure in conjunction with acetaminophen poisoning; and PP-099 that has completed Phase IIa clinical trials for the treatment of acute myocardial infarction.